MetroHealth System: New Use of Inhaled Glucocorticoid Improved Asthma Outcomes for Minority Adults
March 16, 2022
March 16, 2022
CLEVELAND, Ohio, March 16 (TNSJou) -- The MetroHealth System issued the following news release:
The MetroHealth System is helping to put focus on a treatment that will help millions of African American and Hispanic patients who suffer from moderate-to-severe asthma.
In the United States, there are more than 3,300 asthma-attributed deaths in adults each year. Minority patients bear a disproportionate percentage of those incidences. They experience higher rates of asthma- . . .
The MetroHealth System is helping to put focus on a treatment that will help millions of African American and Hispanic patients who suffer from moderate-to-severe asthma.
In the United States, there are more than 3,300 asthma-attributed deaths in adults each year. Minority patients bear a disproportionate percentage of those incidences. They experience higher rates of asthma- . . .